The Pulitzer-prize winning writer and essayist talks about his love of art and how he reconciles two challenging roles.

Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Kodiak collected a total of 38 rock samples from prospecting on the MPD Northwest claim block in 2024. The focus was to obtain representative samples from most mineralized targets to confirm grades ...

Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs extends cash ...

LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm focused on neurogenetic medicines with a market capitalization of $290 million, announced today it is reassessing its ...

A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.

Hamilton, Bermuda. February 12, 2025 Key information relating to return of capital and distribution of BW LPG shares to be paid and transferred by Avance Gas Holding Ltd for the fourth quarter 2024 ...

New three-month data from a study of non-human primates underpins the biotech firm's decision to amend the small interfering RNA program.

"I am a women's health provider at a federally qualified health center and public hospital, and I've never been so scared for ...

On Monday, February 10, at 4:26 p.m., Snohomish Regional Fire & Rescue (SRFR) was dispatched to the 12900 block of SR-522, ...

Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the "Company" or "Proficient") today reported its preliminary financial results for the three months ended December ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...